Home » Stocks » HCYT

H-CYTE, Inc. (HCYT)

Stock Price: $0.0500 USD 0.0030 (6.38%)
Updated May 3, 2021 12:43 PM EDT - Market open
Market Cap 4.60M
Revenue (ttm) 2.15M
Net Income (ttm) -6.78M
Shares Out 136.11M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 3
Last Price $0.0500
Previous Close $0.0470
Change ($) 0.0030
Change (%) 6.38%
Day's Open 0.0507
Day's Range 0.0466 - 0.0507
Day's Volume 31,100
52-Week Range 0.0060 - 0.1500

News

There are no news available yet.

About HCYT

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute biologics for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

Industry
Medical Devices
Stock Exchange
OTCMKTS
Ticker Symbol
HCYT
Full Company Profile

Financial Performance

In 2020, H-CYTE, Inc.'s revenue was $2.15 million, a decrease of -74.23% compared to the previous year's $8.35 million. Losses were -$6.46 million, -78.33% less than in 2019.

Financial Statements